A non-interventional observational retrospective study for the study of the risk factors associated to the related to treatment adverse events occurred by the administration of allergen specific immunotherapy administered by sublingual route (ALK-SLI-2013-01)

10/03/2014
27/02/2019
EU PAS number:
EUPAS6012
Study
Finalised
Documents
Study protocol
Initial protocol
English (698.08 KB - PDF) View document
Study results
Study report
Other information
Publications